Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

FDA – OTAT Town Hall: Cell Therapy Chemistry, Manufacturing, and Controls (Cell and Gene Therapy Catapult – Regulatory Round-up – October 2022)

On the 7th of December 2022, the FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual town hall to answer stakeholder questions related to cell therapy chemistry, manufacturing, and controls (CMC), including tissue-engineered medical products regulated by OTAT. This event is part of a series to answer questions from stakeholders about a variety of topics on which OTAT has regulatory oversight.

Please find details of this webinar here and the recording of the first event held on the 29th of September 2022 here.

See all of Catapult’s Regulatory Round-up for October 2022 here. Published on the 7th of November 2022.


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (25 janvier 2023). FDA – OTAT Town Hall: Cell Therapy Chemistry, Manufacturing, and Controls (Cell and Gene Therapy Catapult – Regulatory Round-up – October 2022). ELSIBI. Consulté le 18 février 2025 à l’adresse https://doi.org/10.58079/o676


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Ce site utilise Akismet pour réduire les indésirables. En savoir plus sur comment les données de vos commentaires sont utilisées.